AgeX Therapeutics Inc logo

AgeX Therapeutics Inc

$ 0.55 -0.006 (-1.08%) 10:08 PM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 20.87M
Enterprise V:
$ 36.28M
Volume:
34.79K
Avg Vol (2M):
25.47K
Also Trade In:
Volume:
34.79K
Market Cap $:
20.87M
PE Ratio:
At Loss
Avg Vol (2-Month):
25.47K
Enterprise Value $:
36.28M
PB Ratio:
0
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develop medicines designed to address some of the unsolved problems in aging. Its PureStem derived cell-based therapeutic candidates in development are AGEX-VASC1, AGEX-BAT1 and AGEX-iTR1547.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.03
Equity-to-Asset -7.52
Debt-to-Equity -1.04
Debt-to-EBITDA -2.19
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -94.87
Distress
Grey
Safe
Beneish M-Score -12.64
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 27.57
9-Day RSI 36.69
14-Day RSI 40.84
6-1 Month Momentum % -8.55
12-1 Month Momentum % 1.29

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.13
Quick Ratio 0.13
Cash Ratio 0.05
Days Sales Outstanding 106.75
Days Payable 18654.31

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1.9

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 75.47
Operating Margin % -13320.75
Net Margin % -18711.32
ROA % -384.86
ROIC % -79.63

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 530.54
EV-to-EBIT -4.99
EV-to-EBITDA -5.08
EV-to-Revenue 684.51
EV-to-FCF -5.79
Earnings Yield (Greenblatt) % -20.04

Financials (Next Earnings Date:2023-03-31 Est.)

AGE's 30-Y Financials

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Gurus Latest Trades with AMEX:AGE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.053
EPS (TTM) ($) -0.26
Beta 0.82
Volatility % 82.81
14-Day RSI 40.84
14-Day ATR ($) 0.041121
20-Day SMA ($) 0.603443
12-1 Month Momentum % 1.29
52-Week Range ($) 0.5162 - 1.39
Shares Outstanding (Mil) 37.95

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

AgeX Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

AgeX Therapeutics Inc Analysis

Share your research

Headlines

See More
No news.